Sa Wang

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

Hong Tang, Wenhong Zhang, Xinyue Chen, 2019, Medicine.

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C

Da-Zhi Zhang, Jun Li, Q. Xie, 2022, World journal of clinical cases.

New Gene Variants Associated with the Risk of Chronic HBV Infection

Jianguo Zhang, D. Zhernakova, Jing Wang, 2020, Virologica Sinica.

New Gene Variants Associated with the Risk of Chronic HBV Infection

S. O’Brien, Jianguo Zhang, D. Zhernakova, 2020, Virologica Sinica.

Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.

Min Yu, C. Si, Yan-Yan Yu, 2015, World journal of gastroenterology.